Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Print1
- Journal1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- English Abstract1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset)1
-
Year
- Journal Title
- Dtsch Med Wochenschr1
Search Results
Sort by
- ArticleBachmann F, Hartl W.Dtsch Med Wochenschr. 1977 Dec 02;102(48):1772-5.MK-231 (Sulindac), 200-400 mg daily, was given to 25 patients with rheumatoid arthritis. The therapeutic response was good and there were no side effects at all. The drug should be used more frequently than heretofore in the drug treatment of symptoms of rheumatoid arthritis.